IPO registrations (S-1, F-1) · Registrants
Instil Bio, Inc.
- SEC CIK
- 1789769 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-02-26, last 2021-03-18; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2021-03-22; declared effective 2021-03-18
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- NY
- Business address
- 3963 MAPLE AVENUE, SUITE 350, Dallas, TX 75219
- EIN
- 83-2072195
- Ticker
- TIL (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Instil Bio, Inc. on the corporate pages
Offering terms
- Proposed price range
- $19.00–$20.00 per share (S-1/A filed 2021-03-18)
- Final price
- $20.00 per share, within the range (424B4 filed 2021-03-22, an initial public offering)
- Shares sold
- 16,000,000
- Gross proceeds
- $320,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TIL
- Lead underwriters
- Morgan Stanley; Jefferies; Cowen
- Syndicate
- Truist Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INSTIL BIO, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Instil Bio, Inc. Fuzzy (name and state)
- Business registration: INSTIL BIO, INC. Fuzzy (name and state)
- Business registration: INSTIL BIO, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: INSTIL BIO, INC. EXACT (EIN (EXACT))
- Form D issuer: Instil Bio, Inc. EXACT (CIK (EXACT))
- SEC filer: Instil Bio, Inc. EXACT (CIK (EXACT))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-26 | S-1 | S-1 (registration) | Instil Bio, Inc. | 0001193125-21-060613 ↗ |
| 2021-03-15 | S-1/A | S-1/A (amendment) | Instil Bio, Inc. | 0001193125-21-080468 ↗ |
| 2021-03-18 | S-1/A | S-1/A (amendment) | Instil Bio, Inc. | 0001193125-21-085124 ↗ |
| 2021-03-18 | EFFECT | EFFECT (declared effective) | Instil Bio, Inc. | 9999999995-21-001004 ↗ |
| 2021-03-22 | 424B4 | 424B4 (final prospectus) | Instil Bio, Inc. | 0001193125-21-089579 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-18 | S-1/A | registration statement | $19.00–$20.00 | 16,000,000 | - | Nasdaq TIL | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2021-03-22 | 424B4 | final prospectus | $20.00 | 16,000,000 | $320,000,000 | Nasdaq TIL | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Binder Gwendolyn | Director | 7 | 2021–2026 | ||
| Chiruvolu Vijay | Officer | Chief Technical Officer | 5 | 2021–2022 | |
| Crouch Bronson | Director,Officer,TenPercentOwner | CEO and Chairman | 11 | 2021–2025 | |
| Curative Ventures V LLC | TenPercentOwner | 3 | 2021 | ||
| Gibson Neil W | Director | 7 | 2021–2026 | ||
| Laumas Sandeep | Officer | CFO and CBO | 10 | 2021–2025 | |
| Matcham George | Director | 7 | 2021–2026 | ||
| McGaughy R Kent Jr | Director | 10 | 2021–2026 | ||
| Nielsen Jack | Director; Director,TenPercentOwner | 6 | 2021–2024 | ||
| Roberts Zachary | Officer | Chief Medical Officer | 6 | 2021–2022 | |
| Shah Nimish P | Director | 4 | 2021 | ||
| Vivo Capital Fund IX, L.P. | TenPercentOwner | 3 | 2021 | ||
| Vivo Capital IX, LLC | TenPercentOwner | 3 | 2021 | ||
| Ray Sumita | Officer | Chief Legal and Admin Officer | 2 | 2022–2023 | |
| MOORE TIMOTHY L. | Officer | Chief Operating Officer | 2 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-02-23 | Instil Bio, Inc. | Biotechnology | $185,449,881 | $185,449,881 | 26 | 1 |
| 2020-08-05 | Instil Bio, Inc. | Biotechnology | $515,917 | $515,917 | 1 | 1 |
| 2020-08-05 | Instil Bio, Inc. | Biotechnology | $170,199,973 | $170,199,973 | 15 | 1 |
| 2019-09-30 | Instil Bio, Inc. | Biotechnology | $25,000,000 | $25,000,000 | 1 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Instil Bio, Inc. | TX | State business registries | name and state |
| Business registration | INSTIL BIO, INC. | TX | State business registries | name and state |
| Business registration | INSTIL BIO, INC. | TX | State business registries | name and state |
| Business registration | INSTIL BIO, INC. | TX | State business registries | name and state |
| Plan sponsor | INSTIL BIO, INC. | TX | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Instil Bio, Inc. | TX | Form D private offerings | CIK (EXACT) |
| Patent assignee | Instil Bio, Inc. | TX | Patents (USPTO) | name and state |
| SEC filer | Instil Bio, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | INSTIL BIO INC. | TX | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | INSTIL BIO, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), TX first:
- ILEX ONCOLOGY INC TX
- HEMOBIOTECH, INC. TX
- Peloton Therapeutics, Inc. TX
- Alpha Cognition Inc. TX
- Kiromic Biopharma, Inc. TX
- Taysha Gene Therapies, Inc. TX
- CG Oncology, Inc. TX
- Voyager Acquisition Corp./Cayman Islands TX
- STEM CELL INNOVATIONS, INC. TX
- REPROS THERAPEUTICS INC. TX
In other datasets, the same topic (Health) in TX:
- Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health